Skip to content

Clinical trials

Phase 3 Kidney Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 3 Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20049
20054
20067
20076
20085
20094
20105
20113
20124
20134
20146
20154
20162
20174
20183
20193
20202
20211
20222
20236
20242
20259
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Recruiting10
Active, not recruiting8
Terminated8
Unknown status7
Withdrawn4
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen13
AstraZeneca4
Novartis Pharmaceuticals4
AbbVie3
Eli Lilly and Company3
Akebia Therapeutics2
Bayer2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Kaiser Permanente2
Mayo Clinic2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases110
Renal Insufficiency, Chronic40
Renal Insufficiency16
Kidney Failure, Chronic15
Anemia14
Diabetes Mellitus, Type 210
Diabetic Nephropathies9
Glomerulonephritis7
Urologic Diseases7
Diabetes Mellitus6

Trials

Showing 26 to 50 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.